APO Research
Talk to an analyst

APO RESEARCH · REPORT

Voriconazole

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Voriconazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025191 pages

Choose your research edition.

Industry ResearchVoriconazole Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Voriconazole Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Voriconazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Voriconazole Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Voriconazole Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Voriconazole market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Voriconazole include Abbott, Takeda, Teva, Sandoz, 诺华, Mylan, Pfizer, GSK and Taj Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Voriconazole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Voriconazole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Voriconazole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Voriconazole market size, projected growth trends, production technologies, key applications, and end-use industries.

Voriconazole Segment by Company

Abbott

Takeda

Teva

Sandoz

诺华

Mylan

Pfizer

GSK

Taj Pharmaceuticals

Squibb

Sichuan Beauty Sport Huakang Pharmaceutical

Macherey-Nagel GmbH

Jincheng HEALTH Pharmaceutical

GeneTech Pharm

Ebang Pharmaceutical

Daiichi Sankyo

Cilag AG

Aditya Pharma

Voriconazole Segment by Type

Injection Voriconazole

Voriconazole Freeze-dried Powder

Voriconazole Segment by Application

Hospital

Clinic

Other

Voriconazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voriconazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Voriconazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voriconazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Voriconazole market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Voriconazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Voriconazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Voriconazole Industry Trends Table 2. Voriconazole Industry Drivers Table 3. Voriconazole Industry Opportunities and Challenges Table 4. Voriconazole Industry Restraints Table 5. Global Voriconazole Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Voriconazole Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Voriconazole Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Voriconazole Sales Market Share by Manufacturers Table 9. Global Voriconazole Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Voriconazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Voriconazole Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Voriconazole Manufacturers, Product Type & Application Table 13. Global Voriconazole Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Voriconazole by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Voriconazole Table 17. Major Manufacturers of Voriconazole Freeze-dried Powder Table 18. Global Voriconazole Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Voriconazole Sales by Type (2021-2026) & (K Units) Table 20. Global Voriconazole Sales by Type (2027-2032) & (K Units) Table 21. Global Voriconazole Sales Market Share by Type (2021-2026) Table 22. Global Voriconazole Sales Market Share by Type (2027-2032) Table 23. Global Voriconazole Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Voriconazole Revenue by Type (2021-2026) & (K Units) Table 25. Global Voriconazole Revenue by Type (2027-2032) & (K Units) Table 26. Global Voriconazole Revenue Market Share by Type (2021-2026) Table 27. Global Voriconazole Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Voriconazole Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Voriconazole Sales by Application (2021-2026) & (K Units) Table 33. Global Voriconazole Sales by Application (2027-2032) & (K Units) Table 34. Global Voriconazole Sales Market Share by Application (2021-2026) Table 35. Global Voriconazole Sales Market Share by Application (2027-2032) Table 36. Global Voriconazole Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Voriconazole Revenue by Application (2021-2026) & (K Units) Table 38. Global Voriconazole Revenue by Application (2027-2032) & (K Units) Table 39. Global Voriconazole Revenue Market Share by Application (2021-2026) Table 40. Global Voriconazole Revenue Market Share by Application (2027-2032) Table 41. Global Voriconazole Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Voriconazole Sales by Region (2021-2026) & (K Units) Table 43. Global Voriconazole Sales Market Share by Region (2021-2026) Table 44. Global Voriconazole Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Voriconazole Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Voriconazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Voriconazole Sales by Country (2021-2026) & (K Units) Table 48. North America Voriconazole Sales by Country (2027-2032) & (K Units) Table 49. Europe Voriconazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Voriconazole Sales by Country (2021-2026) & (K Units) Table 51. Europe Voriconazole Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Voriconazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Voriconazole Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Voriconazole Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Voriconazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Voriconazole Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Voriconazole Sales by Country (2027-2032) & (K Units) Table 58. Global Voriconazole Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Voriconazole Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Voriconazole Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Voriconazole Revenue Market Share by Region (2021-2026) Table 62. Global Voriconazole Revenue Market Share by Region (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Voriconazole Product Portfolio Table 67. Abbott Recent Development Table 68. Takeda Company Information Table 69. Takeda Business Overview Table 70. Takeda Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Takeda Voriconazole Product Portfolio Table 72. Takeda Recent Development Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Teva Voriconazole Product Portfolio Table 77. Teva Recent Development Table 78. Sandoz Company Information Table 79. Sandoz Business Overview Table 80. Sandoz Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sandoz Voriconazole Product Portfolio Table 82. Sandoz Recent Development Table 83. 诺华 Company Information Table 84. 诺华 Business Overview Table 85. 诺华 Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. 诺华 Voriconazole Product Portfolio Table 87. 诺华 Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mylan Voriconazole Product Portfolio Table 92. Mylan Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pfizer Voriconazole Product Portfolio Table 97. Pfizer Recent Development Table 98. GSK Company Information Table 99. GSK Business Overview Table 100. GSK Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. GSK Voriconazole Product Portfolio Table 102. GSK Recent Development Table 103. Taj Pharmaceuticals Company Information Table 104. Taj Pharmaceuticals Business Overview Table 105. Taj Pharmaceuticals Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Taj Pharmaceuticals Voriconazole Product Portfolio Table 107. Taj Pharmaceuticals Recent Development Table 108. Squibb Company Information Table 109. Squibb Business Overview Table 110. Squibb Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Squibb Voriconazole Product Portfolio Table 112. Squibb Recent Development Table 113. Sichuan Beauty Sport Huakang Pharmaceutical Company Information Table 114. Sichuan Beauty Sport Huakang Pharmaceutical Business Overview Table 115. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio Table 117. Sichuan Beauty Sport Huakang Pharmaceutical Recent Development Table 118. Macherey-Nagel GmbH Company Information Table 119. Macherey-Nagel GmbH Business Overview Table 120. Macherey-Nagel GmbH Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Macherey-Nagel GmbH Voriconazole Product Portfolio Table 122. Macherey-Nagel GmbH Recent Development Table 123. Jincheng HEALTH Pharmaceutical Company Information Table 124. Jincheng HEALTH Pharmaceutical Business Overview Table 125. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio Table 127. Jincheng HEALTH Pharmaceutical Recent Development Table 128. GeneTech Pharm Company Information Table 129. GeneTech Pharm Business Overview Table 130. GeneTech Pharm Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. GeneTech Pharm Voriconazole Product Portfolio Table 132. GeneTech Pharm Recent Development Table 133. Ebang Pharmaceutical Company Information Table 134. Ebang Pharmaceutical Business Overview Table 135. Ebang Pharmaceutical Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Ebang Pharmaceutical Voriconazole Product Portfolio Table 137. Ebang Pharmaceutical Recent Development Table 138. Daiichi Sankyo Company Information Table 139. Daiichi Sankyo Business Overview Table 140. Daiichi Sankyo Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Daiichi Sankyo Voriconazole Product Portfolio Table 142. Daiichi Sankyo Recent Development Table 143. Cilag AG Company Information Table 144. Cilag AG Business Overview Table 145. Cilag AG Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Cilag AG Voriconazole Product Portfolio Table 147. Cilag AG Recent Development Table 148. Aditya Pharma Company Information Table 149. Aditya Pharma Business Overview Table 150. Aditya Pharma Voriconazole Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Aditya Pharma Voriconazole Product Portfolio Table 152. Aditya Pharma Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Voriconazole Distributors List Table 156. Voriconazole Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Voriconazole Product Image Figure 2. Global Voriconazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Voriconazole Market Size (2021-2032) & (US$ Million) Figure 4. Global Voriconazole Sales (2021-2032) & (K Units) Figure 5. Global Voriconazole Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Voriconazole Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Voriconazole Image Figure 9. Voriconazole Freeze-dried Powder Image Figure 10. Global Voriconazole Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Voriconazole Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Voriconazole Sales Market Share by Type (2021-2032) Figure 13. Global Voriconazole Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Voriconazole Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Voriconazole Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Voriconazole Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Voriconazole Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Voriconazole Sales Market Share by Application (2021-2032) Figure 22. Global Voriconazole Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Voriconazole Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Voriconazole Revenue Market Share by Application (2021-2032) Figure 25. North America Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Voriconazole Sales Market Share by Country (2021-2032) Figure 27. U.S. Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Voriconazole Sales Market Share by Country (2021-2032) Figure 32. Germany Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Voriconazole Sales Market Share by Country (2021-2032) Figure 39. China Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Voriconazole Sales Market Share by Country (2021-2032) Figure 47. Brazil Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Voriconazole Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Voriconazole Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Voriconazole Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Voriconazole Revenue (2021-2032) & (US$ Million) Figure 58. North America Voriconazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Voriconazole Revenue (2021-2032) & (US$ Million) Figure 60. Europe Voriconazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Voriconazole Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Voriconazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Voriconazole Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Voriconazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Voriconazole Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Voriconazole Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Voriconazole
  • Voriconazole Freeze-dried Powder
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Takeda
  • Teva
  • Sandoz
  • 诺华
  • Mylan
  • Pfizer
  • GSK
  • Taj Pharmaceuticals
  • Squibb
  • Sichuan Beauty Sport Huakang Pharmaceutical
  • Macherey-Nagel GmbH
  • Jincheng HEALTH Pharmaceutical
  • GeneTech Pharm
  • Ebang Pharmaceutical
  • Daiichi Sankyo
  • Cilag AG
  • Aditya Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Voriconazole Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Voriconazole Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Voriconazole Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Voriconazole Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Voriconazole Market Dynamics
  1. 2.1 Voriconazole Industry Trends
  2. 2.2 Voriconazole Industry Drivers
  3. 2.3 Voriconazole Industry Opportunities and Challenges
  4. 2.4 Voriconazole Industry Restraints
3 Voriconazole Market by Manufacturers
  1. 3.1 Global Voriconazole Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Voriconazole Sales by Manufacturers (2021-2026)
  3. 3.3 Global Voriconazole Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Voriconazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Voriconazole Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Voriconazole Manufacturers, Product Type & Application
  7. 3.7 Global Voriconazole Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Voriconazole Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Voriconazole Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Voriconazole Tier 1, Tier 2, and Tier 3
4 Voriconazole Market by Type
  1. 4.1 Voriconazole Type Introduction
  2. 4.1.1 Injection Voriconazole
  3. 4.1.2 Voriconazole Freeze-dried Powder
  4. 4.2 Global Voriconazole Sales by Type
  5. 4.2.1 Global Voriconazole Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Voriconazole Sales by Type (2021-2032)
  7. 4.2.3 Global Voriconazole Sales Market Share by Type (2021-2032)
  8. 4.3 Global Voriconazole Revenue by Type
  9. 4.3.1 Global Voriconazole Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Voriconazole Revenue by Type (2021-2032)
  11. 4.3.3 Global Voriconazole Revenue Market Share by Type (2021-2032)
5 Voriconazole Market by Application
  1. 5.1 Voriconazole Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Voriconazole Sales by Application
  6. 5.2.1 Global Voriconazole Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Voriconazole Sales by Application (2021-2032)
  8. 5.2.3 Global Voriconazole Sales Market Share by Application (2021-2032)
  9. 5.3 Global Voriconazole Revenue by Application
  10. 5.3.1 Global Voriconazole Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Voriconazole Revenue by Application (2021-2032)
  12. 5.3.3 Global Voriconazole Revenue Market Share by Application (2021-2032)
6 Global Voriconazole Sales by Region
  1. 6.1 Global Voriconazole Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Voriconazole Sales by Region (2021-2032)
  3. 6.2.1 Global Voriconazole Sales by Region (2021-2026)
  4. 6.2.2 Global Voriconazole Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Voriconazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Voriconazole Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Voriconazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Voriconazole Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Voriconazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Voriconazole Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Voriconazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Voriconazole Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Voriconazole Revenue by Region
  1. 7.1 Global Voriconazole Revenue by Region
  2. 7.1.1 Global Voriconazole Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Voriconazole Revenue by Region (2021-2026)
  4. 7.1.3 Global Voriconazole Revenue by Region (2027-2032)
  5. 7.1.4 Global Voriconazole Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Voriconazole Revenue (2021-2032)
  8. 7.2.2 North America Voriconazole Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Voriconazole Revenue (2021-2032)
  11. 7.3.2 Europe Voriconazole Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Voriconazole Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Voriconazole Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Voriconazole Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Voriconazole Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Voriconazole Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Voriconazole Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Voriconazole Product Portfolio
  18. 8.3.5 Teva Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Voriconazole Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 诺华
  26. 8.5.1 诺华 Company Information
  27. 8.5.2 诺华 Business Overview
  28. 8.5.3 诺华 Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 诺华 Voriconazole Product Portfolio
  30. 8.5.5 诺华 Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Voriconazole Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Voriconazole Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GSK Voriconazole Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Taj Pharmaceuticals
  50. 8.9.1 Taj Pharmaceuticals Company Information
  51. 8.9.2 Taj Pharmaceuticals Business Overview
  52. 8.9.3 Taj Pharmaceuticals Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Taj Pharmaceuticals Voriconazole Product Portfolio
  54. 8.9.5 Taj Pharmaceuticals Recent Developments
  55. 8.10 Squibb
  56. 8.10.1 Squibb Company Information
  57. 8.10.2 Squibb Business Overview
  58. 8.10.3 Squibb Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Squibb Voriconazole Product Portfolio
  60. 8.10.5 Squibb Recent Developments
  61. 8.11 Sichuan Beauty Sport Huakang Pharmaceutical
  62. 8.11.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
  63. 8.11.2 Sichuan Beauty Sport Huakang Pharmaceutical Business Overview
  64. 8.11.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio
  66. 8.11.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments
  67. 8.12 Macherey-Nagel GmbH
  68. 8.12.1 Macherey-Nagel GmbH Company Information
  69. 8.12.2 Macherey-Nagel GmbH Business Overview
  70. 8.12.3 Macherey-Nagel GmbH Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Macherey-Nagel GmbH Voriconazole Product Portfolio
  72. 8.12.5 Macherey-Nagel GmbH Recent Developments
  73. 8.13 Jincheng HEALTH Pharmaceutical
  74. 8.13.1 Jincheng HEALTH Pharmaceutical Company Information
  75. 8.13.2 Jincheng HEALTH Pharmaceutical Business Overview
  76. 8.13.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio
  78. 8.13.5 Jincheng HEALTH Pharmaceutical Recent Developments
  79. 8.14 GeneTech Pharm
  80. 8.14.1 GeneTech Pharm Company Information
  81. 8.14.2 GeneTech Pharm Business Overview
  82. 8.14.3 GeneTech Pharm Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 GeneTech Pharm Voriconazole Product Portfolio
  84. 8.14.5 GeneTech Pharm Recent Developments
  85. 8.15 Ebang Pharmaceutical
  86. 8.15.1 Ebang Pharmaceutical Company Information
  87. 8.15.2 Ebang Pharmaceutical Business Overview
  88. 8.15.3 Ebang Pharmaceutical Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ebang Pharmaceutical Voriconazole Product Portfolio
  90. 8.15.5 Ebang Pharmaceutical Recent Developments
  91. 8.16 Daiichi Sankyo
  92. 8.16.1 Daiichi Sankyo Company Information
  93. 8.16.2 Daiichi Sankyo Business Overview
  94. 8.16.3 Daiichi Sankyo Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Daiichi Sankyo Voriconazole Product Portfolio
  96. 8.16.5 Daiichi Sankyo Recent Developments
  97. 8.17 Cilag AG
  98. 8.17.1 Cilag AG Company Information
  99. 8.17.2 Cilag AG Business Overview
  100. 8.17.3 Cilag AG Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cilag AG Voriconazole Product Portfolio
  102. 8.17.5 Cilag AG Recent Developments
  103. 8.18 Aditya Pharma
  104. 8.18.1 Aditya Pharma Company Information
  105. 8.18.2 Aditya Pharma Business Overview
  106. 8.18.3 Aditya Pharma Voriconazole Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Aditya Pharma Voriconazole Product Portfolio
  108. 8.18.5 Aditya Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Voriconazole Value Chain Analysis
  2. 9.1.1 Voriconazole Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Voriconazole Production Mode & Process
  6. 9.2 Voriconazole Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Voriconazole Distributors
  9. 9.2.3 Voriconazole Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst